Initiator Pharma A/S (STO:INIT)

Initiator Pharma Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	371	385	485	317	356	133
Market Cap Growth	-20.69%	-20.69%	52.80%	-10.94%	167.93%	-29.18%
Enterprise Value	350	366	475	268	318	121
Last Close Price	6.60	6.85	9.24	6.06	8.14	4.51
Forward PE	4.67	11.25	16.59	7.36	-	-
PB Ratio	16.32	16.93	29.13	6.23	7.36	6.84
P/TBV Ratio	16.93	16.93	29.13	6.23	7.36	6.84
Debt / Equity Ratio	-	-	1.38	0.37	0.38	-
Quick Ratio	29.95	29.95	9.34	26.54	7.10	13.01
Current Ratio	29.95	29.95	9.34	27.70	9.91	13.06
Return on Equity (ROE)	-99.69%	-99.69%	-101.24%	-111.44%	-85.27%	-71.53%
Return on Assets (ROA)	-40.21%	-40.21%	-43.24%	-51.13%	-41.61%	-48.68%
Return on Capital (ROIC)	-43.81%	-43.81%	-46.16%	-54.99%	-46.00%	-54.13%
Earnings Yield	-5.36%	-5.17%	-7.04%	-18.15%	-8.18%	-8.83%
FCF Yield	-4.83%	-4.83%	-5.43%	-15.43%	-13.23%	-8.18%
Buyback Yield / Dilution	0.00%	0.00%	-7.60%	-51.69%	-28.18%	-12.92%

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.